FARINA, ELISA
FARINA, ELISA
Universita' degli Studi di MILANO
Clinical Value of Tissue Transglutaminase Antibodies in Celiac Patients over a Long Term Follow-Up
2021 E. Farina, L. Roncoroni, V. Lombardo, A. Scricciolo, M. Vecchi, L. Doneda, L. Elli
Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Β-Blocker Therapy
2021 G. Tosetti, E. Degasperi, E. Farina, R. D'Ambrosio, R. Soffredini, M. Borghi, V. La Mura, M. Primignani, P. Lampertico
Hesitancy toward the Full COVID-19 Vaccination among Kidney, Liver and Lung Transplant Recipients in Italy
2022 A. Costantino, L. Corinna Morlacchi, M. Francesca Donato, A. Gramegna, E. Farina, C. Dibenedetto, M. Campise, M. Redaelli, M. Perego, C.M. Alfieri, F.B.A. Blasi, P. Lampertico, E. Favi
Noninvasive testing in the management of children with suspected inflammatory bowel disease
2019 D. Dilillo, G.V. Zuccotti, E. Galli, F. Meneghin, A. Dell'Era, F. Penagini, G. Colella, P. Lewindon, S. Carmagnola, E. Farina, S. Ardizzone, G. Maconi
P.07.9 DIETARY HABITS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
2019 A. Dell'Era, M. Magistroni, E. Farina, R. Madoi, L. Cioni, A. Boggio, F. Muzio, S. Ardizzone
Preprocedural prophylaxis with blood products in patients with cirrhosis: Results from a survey of the Italian association for the study of the liver (AISF)
2022 G. Tosetti, E. Farina, R. Caccia, A. Sorge, A. Berzuini, L. Valenti, D. Prati, A. Tripodi, P. Lampertico, M. Primignani
TLL1 Variants do not predict hepatocellular carcinoma development in hcv cirrhotic patients treated with direct-acting antivirals
2019 E. Degasperi, E. Galmozzi, F. Facchetti, E. Farina, R. D'Ambrosio, R. Soffredini, M. Iavarone, P. Lampertico
Urgent surgery for inflammatory bowel diseases during the COVID-19 outbreak in a high incidence area - Experience from a high-volume centre
2020 F. Botti, S. Mazza, S. Costa, E. Farina, L. Baldari, M. Prati